| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.06 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |